AKBA

NASDAQStock

Akebia Therapeutics, Inc.

$1.40+0.00 (+0.00%)

52-Week Range

$1.18

$4.01

Key Stats

Market Cap

375.0M

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.40

Volume

2.2M

Avg Volume

3.2M

Performance

-9.68%

-13.04%

-52.05%

YTD

-9.68%

-17.16%

+104.92%

-61.11%

Price Chart

ETF Exposure

AKBA is held by 51 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
VIRS	Pacer BioThreat Strategy ETF	0.00%	6,483	$9K	$3.7M	0.70%

PreviousPage 2 of 2

About AKBA ETF Exposure

Akebia Therapeutics, Inc. (AKBA) is held by 51 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 375.0M, AKBA is a widely held institutional stock. The stock currently trades at $1.40. Investors can gain exposure to AKBA through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold AKBA, sorted by portfolio weight.